Richard Scolyer Announces Brain Cancer Recurrence, Given Three Months to Live

Renowned melanoma pathologist Richard Scolyer has disclosed that his brain cancer, glioblastoma, has recurred, with doctors estimating he has only three months to live. After initially being diagnosed in July 2023 and undergoing innovative treatments that temporarily rendered him cancer-free, Scolyer faced a new setback following surgery last week, which revealed an aggressive tumor. Expressing gratitude for the time he has had, Scolyer emphasized the importance of making the most of each day amidst his grim prognosis. His pioneering approach to treatment, which involved combining immunotherapy with personalized vaccines, positioned him as a leader in cancer research and earned him recognition as a joint Australian of the Year alongside Professor Georgina Long. Despite the challenges ahead, Scolyer remains focused on spending quality time with his family as he navigates this difficult chapter. With limited options left, he expressed hope for potential drug therapies, acknowledging the low chances of success.